---
title: "argenx announces extraordinary shareholder meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294731060.md"
description: "argenx announced an extraordinary shareholder meeting scheduled for September 17, 2026, in Amsterdam. The primary agenda item is a vote to appoint Thomas M. Brakel and Khurem Farooq as non-executive directors to the company's board."
datetime: "2026-08-03T20:03:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294731060.md)
  - [en](https://longbridge.com/en/news/294731060.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294731060.md)
---

# argenx announces extraordinary shareholder meeting

-   argenx will hold an extraordinary shareholder meeting in Amsterdam on Sept. 17, 2026. \* Shareholders will vote on appointing Thomas M. Brakel and Khurem Farooq as non-executive directors to the board. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. arGEN-X SE published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608031601PRIMZONEFULLFEED1001255872) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)

## Related News & Research

- [argenx (ENXTBR:ARGX) Hits A Phase 3 Win, Is The Upside Fully Priced?](https://longbridge.com/en/news/296529685.md)
- [$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/296119451.md)
- [Argenx Says Phase 3 Alkivia Trial Of Efgartigimod In Autoimmune Myositis Met Primary Endpoint](https://longbridge.com/en/news/296059044.md)
- [ARGX: Efgartigimod achieved significant, sustained improvement in autoimmune myositis in Phase 3](https://longbridge.com/en/news/296061848.md)
- [These Analysts Boost Their Forecasts On Argenx](https://longbridge.com/en/news/296226998.md)